Picture [iito] No Tracking 650x80px
Document › Details

Synpromics Ltd.. (8/29/11). "Press Release: Synpromics Teams with Scottish Enterprise to Accelerate Growth". Edinburgh.

Region Region Scotland
  Country United Kingdom (GB)
Organisations Organisation Synpromics Ltd.
  Group Bayer (Group)
  Organisation 2 Scottish Enterprise
  Group Scotland (govt)
Products Product genomic technology
  Product 2 business development (state/region)

Synpromics Ltd announces the formal support of Scottish Enterprise's High Growth Start-Up Unit (HGSU). Synpromics intends to leverage this valuable affiliation to help drive growth as the company transitions from a start-up business to an established globally-focused corporation in the future.

Dr. Michael Roberts, founder and CEO of Synpromics, commented, "since founding Synpromics in Scotland last year, we've been very impressed with Scottish Enterprise and in particular with the HGSU team. They proven themselves to be very well-connected within the local life sciences community and they truly understand both the challenges and the opportunities facing a start-up company. They have also exhibited both the technical expertise and the global perspective to understand the enormous potential of Synpromics's proven and proprietary technology. With our novel capabilities to optimize gene regulation in even the most complex conditions," Dr. Roberts continued, "Synpromics is positioned to revolutionize numerous biotechnology-driven industries across the life science and green-tech sectors. We welcome Scottish Enterprise's continued assistance in achieving these goals."

Campbell Murray of Scottish Enterprise's HGSU commented, "we recognised at an early stage the potential of this exciting technology and the ambition of the Synpromics team to grow the business into a very profitable global enterprise - we look forward to helping them on the journey."

"From advice and introductions to financial grants and co-investment funds, Scottish Enterprise offers a wealth of support to young companies such as ourselves," commented Andrei Lyne, CFO of Synpromics, "and we've been greatly assisted by the insights and support that the HGSU team has provided to Synpromics thus far. As we establish our operations and seek to build a world-class network of commercial partners and clients, their depth of resources and breadth of contacts will prove invaluable to accelerating the realization of our vision for Synpromics. We look forward to a prosperous affiliation with Scottish Enterprise for many years to come."

About Scottish Enterprise

The High Growth Start-Up team at Scottish Enterprise provides intensive support for businesses where intellectual assets or know-how has the potential for exploitation in global markets. The team helps with developing the business plan, securing funding, building management teams and protecting assets. For more information visit the SE HGSU website.

About Synpromics Ltd

Synpromics Ltd is a biotech company incorporated to develop and commercialize a portfolio of synthetic promoters that can be used to control genes under a variety of settings. The synthetic promoters produced by Synpromics will have applications in life science R&D, biologics production, novel diagnostics, gene therapy, green-tech and agricultural biotechnology. For more information please contact Synpromics.

Record changed: 2019-08-13


Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Bayer (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80

» top